Related Experiment Video
Updated: Jan 24, 2026

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
Published on: October 11, 2024
Successful Resolution of a Large Left Atrial and Left Atrial Appendage Thrombus with Rivaroxaban
Safwan Gaznabi1, Ashraf Abugroun1, Hasan Mahbub2
1Department of Internal Medicine, Advocate Illinois Masonic Medical Center, 836 W Wellington Ave., Chicago, IL 60657, USA.
Insights
Rivaroxaban effectively resolved a large left atrial appendage thrombus in a heart failure patient with atrial fibrillation. Further studies are needed to confirm direct oral anticoagulants
Area of Science:
- Cardiology
- Pharmacology
Background:
- Atrial fibrillation frequently leads to intracardiac thrombus formation, posing a risk for thromboembolic events.
- Transesophageal echocardiography (TEE) is crucial for diagnosing left atrial appendage thrombi.
- Warfarin has been the standard anticoagulant, but direct oral anticoagulants (DOACs) are increasingly used.
Observation:
- A 79-year-old male with heart failure and atrial fibrillation presented with a large, mobile left atrial appendage thrombus.
- The patient opted for rivaroxaban over warfarin for anticoagulation therapy.
- Repeat TEE after 3 months of rivaroxaban showed complete resolution of the thrombus.
Findings:
- Rivaroxaban demonstrated efficacy in resolving a significant left atrial appendage thrombus.
- This case suggests potential for DOACs in treating intracardiac thrombi, though data is limited.
- Successful thrombus lysis with rivaroxaban was confirmed by TEE.
Implications:
- This case supports the investigation of DOACs for intracardiac thrombus treatment.
- DOACs may offer improved patient compliance, reduced hospital stays, and enhanced treatment efficacy compared to warfarin.
- Further clinical trials are warranted to establish the role and effectiveness of DOACs in managing intracardiac thrombi.
Abstract:
A 79-year-old male was admitted to the hospital for acute exacerbation of heart failure. The patient had history of atrial fibrillation and was planned for cardioversion. Preprocedure transesophageal echocardiogram (TEE) revealed a large multilobulated mobile thrombus in the left atrial appendage. The patient refused warfarin therapy and instead chose to take rivaroxaban. Upon outpatient follow-up, 3 months later, no visible thrombus was appreciated on repeat TEE. This case demonstrates successful resolution of left atrial and left atrial appendage thrombi with the use of rivaroxaban. At present time, limited data is available to support the use of rivaroxaban for treatment of intracardiac thrombi. This case highlights the need for further studies to investigate the outcomes and relative efficiency of use of direct oral anticoagulants (DOACs) in lysis of intracardiac thrombus. The benefits of DOACs compared to the standard of therapy could increase patient compliance, reduce length of stay, and improve treatment efficacy.
More Related Videos
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Ecological Succession
Cardiac Catheterization III: Left Heart Catheterization
Surface Appendages of Archaea
Chromatographic Resolution
The effectiveness of separation can be evaluated by determining the level of separation between two neighboring peaks in a chromatogram, which represents the individual components of a sample.
In chromatography,...
Racemic Mixtures and the Resolution of Enantiomers

